A gene (btrC2) encoding the 20-kDa subunit of 2-deoxy-scyllo-inosose (DOI) synthase, a key enzyme in the biosynthesis of 2-deoxystreptamine, was identiˆed from the butirosin-producer Bacillus circulans by reverse genetics. The deduced amino acid sequence of BtrC2 closely resembled that of YaaE of B. subtilis, but the function of the latter has not been known to date. Instead, BtrC2 appeared to show sequence similarity to a certain extent with HisH of B. subtilis, an amidotransferase subunit of imidazole glycerol phosphate synthase. Disruption of btrC2 reduced the growth rate compared with the wild type, and simultaneously antibiotic producing activity was lost. Addition of NH 4 Cl to the medium complemented only the growth rate of the disruptant, and both the growth rate and antibiotic production were restored by addition of yeast extract. In addition, a heterologous co-expression system of btrC2 with btrC was constructed in Escherichia coli. The simultaneously over-expressed BtrC2 and BtrC constituted a heterodimer, the biochemical features of which resembled those of DOI synthase from B. circulans more than those of the recombinant homodimeric BtrC. Despite the similarity of BtrC2 to HisH the heterodimer showed neither aminotransfer nor amidotransfer activity for 2-deoxy-scyllo-inosose as a substrate. All the observations suggest that BtrC2 is involved not only in the secondary metabolism, but also in the primary metabolism in B. circulans. The function of BtrC2 in the butirosin biosynthesis appears to be indirect, and may be involved in stabilization of DOI synthase and in regulation of its enzyme activity.
1,2)
In view of their chemical structure, aminoglycosides can be classiˆed into two major groups. One is those having an aglycone of fully-substituted aminocyclitol which is shown or proposed to be biosynthesized from myo-inositol. Streptomycin, fortimicin, and spectinomycin are members of this group, and genetic as well as enzymological studies have been reported for their biosynthesis. [3] [4] [5] The other group of aminoglycosides has a common aglycone of 2-deoxystreptamine (DOS), and clinically important major compounds are included in this category, like neomycin, kanamycin, ribostamycin, butirosin, gentamicin, tobramycin, sisomicin, sagamicin etc. The biosynthesis of DOS-containing aminoglycosides have been studied mostly by the use of isotope-tracer technology with whole-cell systems of producing organisms and blocked mutants. [6] [7] [8] [9] [10] However, until recently, no biosynthetic gene of the DOS-containing aminoglycosides has been identiˆed. Genetic analysis was once done on the butirosinproducer Bacillus circulans and a region around the self-resistance gene (butA) was analyzed.
11) While a butirosin-transporter gene (butB ) was found in this particular region, no butirosin biosynthetic gene was identiˆed. The enzymes involved in the biosynthesis of these antibiotics also remained unclear except for some transamination-related enzymes. 12, 13) In our laboratory, much study was devoted to 2-deoxyscyllo-inosose (DOI) synthase (Fig. 1) , the key enzyme for the initial step of DOS biosynthesis, by using isotope-labeled substrates or substrate analogues. [14] [15] [16] [17] [18] [19] The DOI synthase catalyzes the carbocycle-forming reaction from glucose-6-phosphate to DOI using NAD + and Co 2+ as cofactors. The multi-step enzyme process includes theˆrst oxidation at C-4 of glucose-6-phosphate, and subsequent elimination of a phosphate group from the activated ulose intermediate follows to form an enol or enolate intermediate. Subsequent reduction at C-4, the opening of the hemiacetal ring, and the last aldol-type intramolecular condensation between C-1 and C-6 take place consecutively to form DOI. Recently, we puriˆed DOI synthase from the butirosin-producer B. circulans. 20) The enzyme was composed of two subunits with molecular mass of 40-kDa and 20-kDa, respectively, and NAD + and Co 2+ were proved to be necessary for its enzymatic activity. Further, we isolated the gene of the large subunit (btrC ), and over-expressed it in Escherichia coli. 21) Subsequently, the butirosin-biosynthetic gene cluster was found in the locus of btrC. 22) All these works appeared to be theˆrst for both the biosynthetic enzymes and genes of 2-deoxystreptaminecontaining aminoglycoside antibiotics. Surprisingly, heterologously-expressed BtrC showed the over-all enzymatic activity by itself without the presence of the 20-kDa subunit. However, there were some signiˆcant diŠerences between the natural enzyme from B. circulans and the recombinant BtrC expressed in E. coli in views of protein stability and kinetic parameters. Further, we were unable to identify the gene responsible for the 20-kDa subunit around btrC, at least in the regions of up-and downstreams of about. 18 kb. 22) Thus, it appeared to be important and intriguing toˆgure out the features of the 20-kDa subunit.
In this study, we identiˆed the gene of DOI synthase 20-kDa subunit, constructed a gene disruptant, and heterologously expressed it with btrC in E. coli. The properties of the 20-kDa subunit are also discussed on the basis of physiological studies.
Materials and Methods
Organisms. B. circulans SANK72073 was cultured in a butirosin-producing medium as described previously, 20) or in a glucose minimal medium. 23 ) E. coli JM109 was cultured in LB medium or on LB-agar containing 50 mg W ml of ampicilin or 30 mg W ml of kanamycin, when necessary.
Identiˆcation of a partial amino acid sequence of DOI synthase 20-kDa subunit. The N-terminal amino acid sequence of the 20-kDa subunit of DOI synthase was analyzed as follows. Puriˆed DOI synthase from B. circulans was separated into each subunit on 12.5z Tricine-SDS-PAGE, 24) and subsequently transferred to a PVDF membrane (Millipore) by electroblotting. The membrane was stained with Coomassie brilliant blue. A band of interest was excised, and its N-terminal amino acid sequence was analyzed with a protein sequencer, PPSQ-21 (Shimadzu, Japan). Analysis of internal amino acid sequences was done by the APRO Life Science Institute (Japan).
Cloning of the gene. DNA manipulations were done as described in the literature. 25) On the basis of partial amino acid sequences and alignment with known ORFs, oligonucleotides for PCRs primers were designed (Fig. 2, Table 1 ). Nested PCR (949 C for 5 min, and 949 C for 30 sec, t9 C for 30 sec, 729 C for 1 min, in a total of 35 cycles, and then 729 C for 7 min) was done using these primers and B. circulans choromosome as a template for theˆrst PCR, and the second PCR was done with theˆrst PCR product as a template. The second PCR products were subcloned into pT7blue-T vector (Novagen) to obtain pPCR1 to 8. The conditions for nested PCR were 
summarized in Table 2 . The sequences of pPCR1 to 8 were analyzed to design appropriate oligonucleotides for further PCR. The third PCRs were done by using genome libraries of B. circulans as templates, which had previously been constructed by digestion of the chromosome with EcoR I, Hind III, Kpn I, Pst I, Sac I, and Xho I, respectively, and were then subcloned into pBluescriptII SK+ (Stratagene). With one of the designed primers (23k10, 23k11 and 23k20) and T3 primer (or T7 primer) (Tabel 1), PCR was further done (949 C for 5 min, and 949 C for 30 sec, 569 C for 30 sec, 729 C for 2 min, in a total of 35 cycles, and then 729 C for 7 min). The PCR product was subcloned into pT7blue-T vector to obtain pPstC1, pSacC1, pEcoC1, and pXhoC1, and sequenced. From the resulting sequence, appropriate primers for the fourth PCR were designed to amplify the 5?-terminal region of the gene (Tabel 1, 23k21 and 23k22). PCR was done similarly to the third PCR, and the product was further subcloned into pT7blue-T vector to obtain pSacN1 and pSacN2. Based on the sequence of the resulting plasmids, the full region of the target gene was analyzed. In all cases, at least 3 individual clones were analyzed to avoid incorporation of a mismatch in the PCR.
Gene disruption. A DNA fragment (1.8 kb) containing the target gene was ampliˆed by PCR (959 C for 5 min, and 959 C for 1 min, 579 C for 1 min, 729 C for 2 min, in total 30 cycles, and then 729 C for 7 min), using the oligonucleotides of 20kDIS-f and 20kDIS-r (Table 1) as primers. The PCR product was 5?-phosphorylated by T4 polynucleotide kinase, and then subcloned into Sma I-digested pUC119. After the sequence was conˆrmed, a BamH I-EcoR I fragment was recovered and subcloned into a corresponding site of pHB201 (Tanaka et al., unpublished). The resulting plasmid was digested with Nae I (328 bp from the starting codon of btrC2), and a tetracycline-resistance gene cassette (1.9 kb, recovered from pBEST309 26) with Sma I digestion) was inserted in the reverse direction to yield pHB20Tckd. The direction of the tetracycline-resistance gene cassette was conˆrmed by an EcoR I digestion using EcoR I site located at the end of the gene cassette. The resulting plasmid was introduced into wild type of B. circulans, and a gene disruptant was constructed by homologous recombination, according to the method described previously. 22) Disruption of the target gene was conˆrmed by PCR (959 C for 5 min, and 959 C for 1 min, 609 C for 1 min, 729 C for 3 min, in a total of 30 cycles, and then 729 C for 7 min) using the chromosome of the disruptant as a template, and oligonucleotides of 20kDISc-f and 20kDISc-r (Table 1) as primers.
Analysis of antibiotic activity. Wild type and disruptant of B. circulans were cultured in a butirosinproducing medium described previously 16) for 2 days. Each culture was then centrifuged (10,000×g, 15 min), and the supernatant was tested for antibiotic activity by a paper disk diŠusion method. 27) Simultaneous expression of btrC2 with btrC in E. coli. To obtain btrC2 (including the SD sequence) for heterologous expression, primers (20k-fSD and 20k-r, Table 1 ) were designed, and PCR (959 C for 5 min, and 959 C for 1 min, 609 C for 1 min, 729 C for 1 min in total 30 cycles, and then 729 C for 7 min) was done using the B. circulans chromosome as template. PCR products were once subcloned into the pT7 blue-T vector, and digested with Xho I. These fragments were further subcloned into the Xho I site of pDS4, 21) to yield pDS2002. E. coli BL21(DE3) car-rying pDS2002 was cultivated in 4.8 l of LB medium containing 30 mg W ml of kanamycin until OD600 reached to 0.6, and then isopropyl-b-D-thiogalactopyranoside was added to aˆnal concentration of 1 mM. After 2 hours of additional cultivation, cells were harvested by centrifugation (10,000×g, 10 min) and kept at "309 C until use.
Puriˆcation of the expressed protein. The frozen cells (10 g) were thawed, homogenized in 50 mM TrisHCl buŠer (pH 7.7), and disrupted by a sonic oscillator (Soniˆer Type-250, Branson) for a total period of 20 min on an ice bath. Unbroken cells were removed by centrifugation (10,000×g, 10 min) to obtain a cell-free extract. The extract thus obtained was then fractionated by (NH4)2SO4 precipitation. The precipitate obtained by 40z-70z (NH4)2SO4 saturation was dissolved in 40 ml of 50 mM Tris-HCl buŠer (pH 7.7), and the resulting solution was dialyzed against the same buŠer at 49 C for 15 h. The dialysate was then put on a column (2.5×12 cm) of DEAESepharose FF equilibrated with the same buŠer, and absorbed proteins were eluted with a linear gradient of NaCl (0-0.4 M). Enzymatically active fractions were combined, concentrated by ultraˆltration, and then put on a column of Hi Load 26 W 60 Superdex 200 pg equilibrated with 50 mM Tris-HCl buŠer (pH 7.7) containing 0.1 M of NaCl. Enzymatically active fractions were used as enzyme preparations.
Enzyme assay. DOI synthase activity was measured as described previously. 20) Transamination activity was examined as follows. Reaction mixture A was composed of 0.5 mM of pyridoxal-5-phosphate, 25 mM of L-glutamine, 5 mM of NAD + , 10 mM of glucose-6-phosphate, 5 mM of CoCl2, and 2.3 mg of puriˆed BtrC2+BtrC in 50 mM BES buŠer, pH 7.7. Reaction mixture B contained 25 mM of L-glutamine, 5 mM of NAD + , 5 mM of NADH, 10 mM of glucose-6-phosphate, 5 mM of CoCl 2 , and 2.3 mg of puriˆed BtrC2+BtrC in 50 mM BES buŠer, pH 7.7. Reaction mixture C contained 25 mM of L-glutamine, 5 mM of NAD + , 5 mM of NADPH, 10 mM of glucose-6-phosphate, 5 mM of CoCl2, and 2.3 mg of puriˆed BtrC2+BtrC in 50 mM BES buŠer, pH 7.7. The total volume of each mixture was 4 ml. Each reaction mixture was incubated separately at 429 C for 3 h, and the enzyme was removed from the mixtures by ultraˆltration. Six ml of dansyl chloride solution (10 mg W ml in CH3CN), 0.5 ml of 2 N NaOH, and 2 ml of H2O were added to theˆltered reaction mixtures, and the mixtures were incubated separately at 359 C for 3 h. The solvent was removed by ‰ushing with air. Each residue was dissolved in 50 ml of methanol and centrifuged (20,000×g, 10 min) to remove debris. The supernatant thus obtained was separated by preparative TLC with a Merck Kieselgel 60 F254 plates Art 1.05744 (CHCl3:methanol, 5:1), and appropriate bands were extracted with 100 ml of CH3CN. Two ml of each solution was analyzed by HPLC with a Senshu Pak ODS 1251 N column (4.6 mm i.d.×25 cm, Sensyu Scientiˆc, Japan) and a ‰uorescent detector (excitation; 331 nm, emission; 523 nm). The elution was done with a linear gradient of 20-50z CH3CN in 0.2 M sodium acetate with a ‰ow rate of 1 ml W min.
Miscellaneous. DNA sequencing was done with a LONG READIR 4200 (Li-Cor) according to the manufacturer's protocol. PCR was performed by a GeneAmp PCR System 9700 (Amersham Pharmacia) using ExTaq DNA polymerase (Takara, Japan). Oligo DNAs for PCR primer were synthesized in Amersham Pharmacia. Puriˆcation of plasmids was done with a GFX Micro Plasmid Prep Kit (Amersham Pharmacia). Restriction enzymes and modiˆca-tion enzymes were purchased from Takara (Japan). Genome preparations were done with Dr. GENTLE (Takara, Japan). Genetic analysis was done with GENETYX-MAC ver. 10 (Software Development, Japan), and database research was done by FASTA and BLAST2 on the internet. All other reagents were of the highest grade commercially available. Polyacrylamide gel electrophoresis in the absence of SDS was done by the method of Davis, 28) and polyacrylamide gel electrophoresis in the presence of SDS was done by the method of Laemmli.
29)
Accession Number. The sequences analyzed in this study have been deposited in the DDBJ W EMBL W GenBank nucleotide sequence databases with the accession number of AB066209.
Results

Cloning of DOI synthase 20-kDa subunit gene
The N-terminal amino acid sequence of the DOI synthase 20-kDa subunit was analyzed as Fig. 2 . It showed high similarity to the B. subtilis yaaE gene, and a homologue of this latter gene has been found in a number of organisms. However, the functions of all of these genes are still unknown. On the basis of a partial amino acid sequence and a conserved region with other ORFs, oligonucleotides were designed as primers for PCR (Fig. 2, Table 1 ). By using these primers, nested PCR was done with B. circulans chromosome as template for theˆrst PCR (Table 2) .
To obtain the full region of the gene, PCR was done further, as described in Materials and Methods. As a result, the locus of the DOI synthase 20-kDa subunit gene (named as btrC2) was identiˆed (Fig. 3) . The location of the ORF was as same as yaaE in B. subtilis 30) or B. halodurans. 31) BtrC2 showed comparatively high similarity to YaaE of B. subtilis and its homologue. To be noted was that BtrC2 was similar to HisH of B. subtilis, amidotransferase subunit 4 Cl, $; btrC2 disruptant supplemented with 0.5z yeast extract, ; btrC2 disruptant supplemented with 10 mg W ml pyridoxine-HCl of imidazole glycerol phosphate synthase 32) to some extent (Fig. 4) .
Disruption of btrC2 in B. circulans
In order to investigate the physiological function of btrC2, a disruptant of btrC2 was constructed by insertion of a tetracycline-resistance gene cassette. Disruption of btrC2 was conˆrmed by PCR (wild type; 1.4 kb, disruptant; 3.3 kb) and subsequent sequence analysis of the PCR product (data not shown). The disruptant showed more retarded growth than the wild type in a minimal medium (Fig. 5A) , and in a butirosin-producing medium (Fig. 5B) . Growth was restored by adding 0.5z yeast extract (in a butirosin-producing medium) or 0.1 M NH4Cl (in each medium). Addition of pyridoxine had no eŠect on growth. The btrC2 disruptant showed no antibiotic production even in the butirosin-producing medium. Interestingly however, antibiotic activity was recovered when the culture was done in a butirosin-producing medium containing additional 0.5z yeast extract.
Heterologous expression of btrC2 with btrC
To investigate the role of BtrC2 in butirosin biosynthesis, btrC2 was heterologously expressed simultaneously with btrC in E. coli, and the resulting BtrC2 was puriˆed to homogeneity. Interestingly, BtrC2 and BtrC co-migrated into same fractions during all the steps of puriˆcation. The puriˆed enzyme appeared as a single band in polyacrylamide gel electrophoresis in the absence of SDS (Fig. 6A) . This single band was excised and directly analyzed by polyacrylamide gel electrophoresis in the presence of SDS (Fig. 6B) . Apparently, two bands were observed, which corresponded to BtrC2 and BtrC. It should be noted that recombinant BtrC2+BtrC turned out to be stable in the (NH4)2SO4 fractionation or dialyzation, which was in contrast to the observation that recombinant BtrC was easily aggregated by these treatments. 21) In addition, although recombinant btrC lost its activity in a buŠer without Co 2+ , 21) recombinant BtrC2+BtrC was stable under such conditions. Kinetic parameters of recombinant BtrC2+BtrC for the DOI synthase activity were measured, and compared with those of recombinant BtrC homodimer and native DOI synthase from B. circulans (Table 3) . Although various combinations of reaction conditions has been attempted, recombinant BtrC2+BtrC was unable to catalyze any reactions beyond the formation of DOI. Neither an amination product (2-deoxy-scyllo-inosamine) nor a new product was obtained. 
Discussion
In this study, we succeeded in identifying the gene of DOI synthase 20-kDa subunit (ORF3＝btrC2 in Fig. 3 ). The location of btrC2 appeared to be unrelated to the butrosin biosynthetic gene cluster having btrC in the middle, which is the key catalytic subunit of DOI synthase in the DOS biosynthesis. It should be pointed out that sequences similar to btrC2 were found in a number of organisms, and in the most cases, gene similar to ORF2 was accompanied adjacently. Further, the other neighboring ORF1 and ORF4 found in the locus of btrC2 in B. circulans is also shown in B. subtilis 30) and B. halodurans.
31)
These facts suggested that this gene array seems to be distributed widely, at least in Bacilli, and hence btrC2 may participate not only in butirosin biosynthesis, but also in the primary metabolism. An important observation was that BtrC2 showed signiˆcant similarity to HisH, the glutamine amidotransferase subunit of imidazole glycerol phosphate synthase. In the histidine biosynthetic pathway, the HisFH complex catalyzes the reaction of + . 33) Apparently, this fact suggests that the function of the amidotransferase subunit HisH can be complemented by addition of NH4 + . The results in this study that btrC2 disruptant was defective in growth both in the minimal medium and in the butirosin-producing medium, and the growth was complemented by the presence of NH4 + clearly showed that BtrC2 plays a role of amidotransferase in the primary metabolism. An ORF2 homologue was reported to participate in pyridoxine biosynthesis. 34) More recently, it has been shown that the nitrogen atom of pyridoxine originates from the amide nitrogen of glutamine in B. subtilis. 35) Consequently, it seems that BtrC2 is involved in the pyridoxine biosynthesis in B. circulans, probably as an amidotransferase. However, as described above, supplementation of pyridoxine to the culture of btrC2 disruptant could not cure its growth defect. This may suggest that BtrC2 plays a pleiotropic role in the pyridoxine biosynthetic system and other primary metabolisms. In some bacteria, it was already known that p-aminobenzoate synthase and anthranilate synthase share a common amidotransferase subunit, which provides the capacity for amido-transfer to each enzyme. 36) Based on these results and previous works by others, weˆrst assumed a functional sharing between BtrC and BtrC2, that BtrC catalyzes the conversion of glucose-6-phosphate to DOI as already elucidated, and BtrC2 could be an amidotransferase subunit, to yield 2-deoxy-scyllo-inosamine from DOI. So far as we attempted, however, the recombinant BtrC2+BtrC was unable to show such an activity under various conditions. In addition, we identiˆed the L-glutamine:2-deoxy-scyllo-inosose aminotransferase gene (btrS ) from B. circulans quite recently. (Tamegai et al., to be published) These facts appear to suggest that the original assumption for the function of BtrC2+BtrC heterodimer described above is not the case. As to the function of BtrC2, it should be emphasized that, btrC2 disruptant lost its capacity for antibiotic production, and feeding of yeast extract to the culture was able to restore antibiotic production of the disruptant. It seems likely, therefore, that BtrC2 may participate in the butirosin biosynthesis, although in a rather indirect way. The results of simultaneous expression of btrC2 with btrC showed that BtrC2 and BtrC spontaneously form a heterodimeric structure, and the heterodimer was much more stable than the BtrC homodimer. Further, kinetic parameters of recombinant BtrC2+BtrC were more similar to those of DOI synthase from B. circulans than to those of recombinant BtrC. In conclusion, the major role of BtrC2 in butirosin biosynthesis appears to be stabilization and
